BioVie Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BioVie Inc. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $18.48M, a 89.13% increase year-over-year.
- BioVie Inc. stock issued during period, value, new issues for the quarter ending 2023-12-31 was $7.42M, a 77.18% decline year-over-year.
- BioVie Inc. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $1.91M, a 67.72% decline year-over-year.
- BioVie Inc. stock issued during period, value, new issues for the quarter ending 2023-03-31 was $9.77M.
- BioVie Inc. stock issued during period, value, new issues for fiscal 2023 was $49.47M, a 167.22% increase from fiscal 2022.
- BioVie Inc. stock issued during period, value, new issues for fiscal 2022 was $18.51M, a 18.45% increase from fiscal 2021.
- BioVie Inc. stock issued during period, value, new issues for fiscal 2021 was $15.63M.
- BioVie Inc. stock issued during period, value, new issues for fiscal 2018 was $445.00K, a 7.29% decline from fiscal 2017.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-03-31 | $18.48M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $7.42M 10-Q · filed 2024-05-14 | |
| 2023-09-30 | $1.91M 10-Q · filed 2024-05-14 | |
| 2023-06-30 | $49.47M 10-K · filed 2023-08-16 | |
| 2023-03-31 | $9.77M 10-Q · filed 2024-05-14 | |
| 2022-12-31 | $32.52M 10-Q · filed 2024-05-14 | |
| 2022-09-30 | $5.90M 10-Q · filed 2024-05-14 | |
| 2022-06-30 | $18.51M 10-K · filed 2023-08-16 | |
| 2021-09-30 | $18.50M 10-K · filed 2023-08-16 | |
| 2021-06-30 | $15.63M 10-K · filed 2022-09-27 | |
| 2020-09-30 | $15.63M 10-Q · filed 2022-05-11 | |
| 2018-09-30 | $1.15M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $445.00K 10-K · filed 2019-09-27 | |
| 2017-06-30 | $480.00K 10-K · filed 2018-10-05 | |
| 2013-06-30 | $8.21K 10-K · filed 2014-09-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |